Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer

Coralie Poulard1,2,3, Julien Jacquemetton4,5,6, Olivier Trédan7,8,9,10

  • 1Université de Lyon, F-69000 Lyon, France. coralie.poulard@lyon.unicancer.fr.

Insights

Oestrogen receptor alpha (ERα) interactions with Src and PI3K increase in tamoxifen-resistant breast cancer. Inhibiting ERα-Src interactions may restore tamoxifen sensitivity, offering new therapeutic strategies for endocrine resistance.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Endocrine therapies targeting oestrogen signalling are crucial for ERα-positive breast cancer.
  • Treatment resistance remains a significant clinical challenge, limiting therapeutic efficacy.
  • Non-genomic oestrogen signalling via the ERα/Src/PI3K complex is implicated in aggressive breast cancer.

Purpose of the Study:

  • To investigate the role of ERα/Src/PI3K pathway activation in endocrine therapy resistance.
  • To determine if ERα interactions with Src and PI3K are altered in tamoxifen-resistant breast cancer models.
  • To explore the therapeutic potential of targeting ERα-Src interactions to overcome resistance.

Main Methods:

  • Proximity Ligation Assay (PLA) to study ERα interactions with Src and PI3K.
  • Utilized in vitro (MCF-7 cells) and in vivo (patient-derived xenografts) models of tamoxifen resistance.
  • Tested a peptide inhibitor targeting the ERα-Src interaction.

Main Results:

  • Increased ERα/Src and ERα/PI3K interactions were observed in tamoxifen-resistant breast cancer models (MCF-7 cells and PDXs).
  • These specific interactions were not elevated in resistance to other endocrine therapies.
  • A peptide inhibiting ERα-Src interaction partially restored sensitivity to tamoxifen in resistant cells.

Conclusions:

  • Activation of ERα/Src and ERα/PI3K signalling pathways is associated with acquired tamoxifen resistance in breast cancer.
  • The ERα-Src interaction represents a potential therapeutic target to circumvent tamoxifen resistance.
  • Targeting this pathway could offer novel strategies for managing endocrine-resistant breast cancer.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.9K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.0K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K